NCI Recognizes Clinical Investigators with 2013 Cancer Clinical Investigator Team Leadership Award (CCITLA) - 09/30/2013
The NCI has recognized 11 outstanding clinical investigators with a two-year award to acknowledge and support leaders in clinical cancer research programs at NCI Designated Cancer Centers. This fifth cohort of investigators joins a group of 46 other outstanding clinical investigators who received this prestigious award in 2009 – 2012
An updated request for applications from NCI Designated Cancer Centers is anticipated by early 2014.
The goal of the NCTN is to develop and conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therapies and related clinical approaches for both adult and pediatric patients. Comprehensive discussions with all major clinical trial stakeholders and NCI Advisory Boards over a 2-year period led to the development of the new Network structure described in the Funding Opportunity Announcements (FOAs). The NCTN consists of 6 components, each with its own FOA. These components are: Network Group Operations Centers; Network Group Statistics and Data Management Centers; Network Group Integrated Translation Science Support Centers; Lead Academic Participating Site Centers; Network Radiotherapy and Imaging Core Services Centers; and a Canadian Collaborating Clinical Trials Network.
The 22 Clinical Trials Working Group (CTWG) initiatives can be broadly categorized as addressing coordination, scientific prioritization, standardization, operational efficiency, and enterprise-wide concerns.
A central element of NCI's efforts to transform the clinical trials enterprise is the organization of Scientific Steering Committees composed of outside cancer experts and NCI senior investigators.